Driehaus Capital Management LLC

91 employees

Driehaus is an investment management firm that manages growth equity investment strategies and multi-asset alternative strategies.

Investor insights

Sectors invested in

Biotechnology19

Health Care14

Therapeutics9

Pharmaceutical6

Medical6

Life Science4

Health Diagnostics4

Medical Device4

Biopharma3

Genetics3

Artificial Intelligence2

biotechnology2

Behavioral Health1

machine learning1

protein misfolding1

computational chemistry1

Endocrinology1

RareDisease1

Drug Discovery1

Family1

Funding rounds participated in

$80M sweet spot round size

Most of their 25 investments are in rounds between $55M and $130M

Investor type

Private Equity Firm

Basic info

Industry

investment management

Sectors

Financial Services

Finance

Management Consulting

Date founded

1982

Investments made

VectivBio AG raised $125M on October 13, 2022

Investors: TCG X, Surveyor Capital, OrbiMed Advisors, Eventide Asset Management, Marshall Wace, Vivo Capital, Forbion and Driehaus Capital Management LLC

Sonendo®, Inc. raised $63M on September 23, 2022

Investors: First Light Asset Management, Pura Vida Investments and Driehaus Capital Management LLC

Ventyx Biosciences raised $177M on September 19, 2022

Investors: Great Point Partners, Walleye Capital, Logos Global Management, LP, CaaS Capital Management, Woodline Partners LP, Vivo Capital, Redmile Group and Driehaus Capital Management LLC

Annexon Biosciences raised $130M on July 8, 2022

Investors: Adage Capital Management, Redmile Group and Driehaus Capital Management LLC

Congruence Therapeutics raised $50M on February 8, 2022

Investors: Amplitude Ventures, OrbiMed Advisors, Lumira Ventures and Driehaus Capital Management LLC

Maze Therapeutics raised $190M on January 10, 2022

Investors: NS Investment, General Catalyst, Casdin Capital, LLC, Foresite Capital, City Hill Ventures, Woodline Partners LP and Driehaus Capital Management LLC

DiCE Molecules raised $60M on August 24, 2021

Investors: Eventide Asset Management, New Leaf Venture Partners, Soleus Capital Management, L.P., Northpond Ventures, Logos Global Management, LP, Sands Capital Management, Osage University Partners (OUP), RA Capital Management, L.P. and Driehaus Capital Management LLC

Frontier Medicines raised $89M on July 19, 2021

Investors: Woodline Partners LP, RA Capital Management, L.P., DCVC Bio, MPM Capital and Driehaus Capital Management LLC

Nuvalent, Inc. raised $135M on May 11, 2021

Investors: Logos Global Management, LP, Viking Global Investors, Wellington Management and Driehaus Capital Management LLC

Undisclosed raised $200M on May 5, 2021

Investors: RTW Investments, LP, Pura Vida Investments, Woodline Partners LP, Soleus Capital Management, L.P., First Light Asset Management, Farallon Capital Management and Driehaus Capital Management LLC